New insights into medicines for preeclampsia

Burnet Institute researchers have led the development of the first global strategic guidelines—called target product profiles (TPPs)—for medicines to prevent and treat preeclampsia, a hypertensive disorder in pregnancy that's one of the leading causes of maternal deaths, stillbirth, and preterm birth globally.

source https://medicalxpress.com/news/2022-11-insights-medicines-preeclampsia.html